Children born preterm admitted to paediatric intensive care for bronchiolitis: a systematic review and meta-analysis

Tim J van Hasselt1, Kirstin Webster2, Chris Gale3

  • 1Department of Population Health Sciences, University of Leicester, University Rd, Leicester, LE1 7RH, UK. t.vanhasselt@nhs.net.

BMC Pediatrics
|June 29, 2023
PubMed

Insights

Preterm infants represent 31% of pediatric intensive care unit admissions for respiratory syncytial virus (RSV) and bronchiolitis. These infants face a higher risk of mechanical ventilation but not increased mortality.

Area of Science:

  • Pediatric Intensive Care
  • Neonatology
  • Respiratory Medicine

Background:

  • Respiratory Syncytial Virus (RSV) and bronchiolitis are common causes of pediatric intensive care unit (PICU) admissions.
  • Preterm infants are a vulnerable population with potentially different outcomes in PICU.
  • Understanding the proportion and outcomes of preterm infants admitted to the PICU for RSV/bronchiolitis is crucial for resource allocation and care optimization.

Approach:

  • A systematic review and meta-analysis of studies published from 2000 onwards in high-income countries.
  • Searched Medline, Embase, and Scopus databases for relevant literature.
  • Included studies on children aged 0-18 years admitted to PICU for RSV and/or bronchiolitis, assessing the percentage of preterm admissions and risks of ventilation and mortality.

Key Points:

  • 31% of PICU admissions for RSV/bronchiolitis were preterm infants, significantly higher than the general preterm birth rate.
  • Preterm infants had a 1.57 times higher risk of requiring invasive mechanical ventilation compared to term infants.
  • No significant increase in PICU mortality was observed for preterm infants, though overall mortality was low.

Conclusions:

  • Preterm-born children are over-represented in PICU admissions for bronchiolitis.
  • Preterm infants admitted to the PICU for RSV/bronchiolitis face an elevated risk of mechanical ventilation.
  • While mortality risk was not significantly higher, the increased need for ventilation highlights the vulnerability of preterm infants.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
250
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
275
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
166
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
278
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
251